{COPYRIGHT NASAL SPRAY A NEW HOPE FOR LOW MOOD IN EUROPE ?

The introduction of esketamine delivery system represents a significant change in the approach of complex depressive conditions across European markets . While previously requiring in-clinic administration, this method allows for a increased scope of recipient autonomy , although rigorous supervi